UASt regulatory sequences drive expression of Rnor\Chrm3 that has been modified into a designer receptor exclusively activated by a designer drug (DREADD), tagged with Tag:V5. The modified receptor is activated by clozapine-N-oxide (CNO) rather than acetylcholine.